There were significantly lower rates of statin therapy (78.3% vs. 83.8%, p = 0.024) and therapy with ACE-inhibitors or angiotensin receptor blockers (57.7% vs. 68.8%, p < 0.001) amongst the veterans in the ALI cohort, though there was similar utilization of antiplatelet therapy (84.6% vs. 87.7%, p = 0.166) between the two groups (Table 1). This evidence concerns the gene ACE and acute respiratory distress syndrome.